Rat Anti-Mouse CD39 Antibody (S-R641)

產(chǎn)品型號(hào)：S0B5042

更新時(shí)間：2025-10-08

廠商性質(zhì)：生產(chǎn)廠家

訪問量：81

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對(duì)抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

流式抗體封閉：如何有效避免實(shí)驗(yàn)中的假陽性結(jié)果？

ELISA實(shí)驗(yàn)結(jié)果如何科學(xué)解讀？

IHC腫瘤標(biāo)志物 | 常見乳腺癌診斷——助力守護(hù)生命之花

抗獨(dú)特型抗體如何成為抗體藥物研發(fā)的關(guān)鍵工具？

產(chǎn)品介紹

CD39 （Ectonucleoside triphosphate diphosphohydrolase-1, encoded by the ENTPD1 gene） is an ectoenzyme that hydrolyzes extracellular ATP into AMP, serving as the rate-limiting enzyme in the generation of adenosine. In the tumor microenvironment, CD39 works in concert with CD73 to ultimately produce immunosuppressive adenosine, which inhibits antitumor immune responses. CD39 is widely expressed on the surface of various immune cells, including T cells, B cells, natural killer cells, dendritic cells, and macrophages. Due to its critical role in immune suppression, CD39 has emerged as a promising target for cancer immunotherapy, with several inhibitors and antibody drugs currently under clinical investigation.

上一個(gè)：S0B5043Rat Anti-Mouse CD163 Antibody (S-R608)